Testing lower doses of febuxostat in well-controlled gout
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 to 79 years old
- You have taken a gout medication like allopurinol or febuxostat for at least 5 years
- Your uric acid levels have stayed below 6.0 mg/dL for the past 5 years, or the overall pattern was very low
- You do not have any tophi (hard lumps under the skin from gout) that can be felt or seen
- You have not had a gout flare or kidney stone in the last year
- Your kidney function is good (eGFR of 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests whether the weight-loss drug orlistat, along with weight management, helps lower uric acid levels in people who have both gout and obesity. If you qualify, you may receive orlistat or a placebo to see if it reduces gout flare-ups and improves your uric acid control.
This trial studies whether allopurinol can reduce the chance of cardiovascular events like heart attack, stroke, or related problems in people who are at higher risk. It targets people with higher uric acid and other risk factors, to see if lowering uric acid helps protect the heart.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
This study tests whether a pharmacist can help veterans with gout manage their uric acid levels using standard medications, aiming to reduce gout flares. If you've had a gout flare recently and are starting or already taking uric acid-lowering medicine, this might be a good fit.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.